Company profile

Evidation

Population Health & Healthcare Analytics

Company profile

About Evidation

Evidation is a health data platform company that connects directly with millions of individuals to transform real-world health experiences into scientific insights. Founded in 2012 and headquartered in San Mateo, California, Evidation maintains ongoing engagement with 5 million people across 97% of U.S. ZIP codes who participate in a consented, mutual value exchange. The company collects longitudinal, multimodal real-world data including clinical data (EHR and claims), demographic and social context, conditions and treatment experience, patient-reported outcomes, molecular data from biosamples, and digital measures from wearables. This comprehensive data provides the depth and temporal context needed for better insights, evidence generation, and model development. Evidation serves life sciences companies, consumer health companies, government agencies, and non-profit organizations by enabling research, discovery, early development, evidence generation, medical value demonstration, and commercial planning. The platform has supported over 140 real-world studies and contributed to over 100 peer-reviewed publications. More than 90% of top biopharma companies have partnered with Evidation. The company's approach captures continuous data that reflects how patients manage conditions, experience treatment, and change between clinical visits—information that traditional real-world data sources miss. Through the Evidation app, individuals control what data they share, with whom, and for how long, while receiving personalized insights and earning rewards for their participation.

Company description Evidation official website

Primary marketPopulation Health & Healthcare Analytics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Evidation?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • ADHD
  • Anxiety
  • Asthma
  • Atrial Fibrillation
  • Autoimmune diseases
  • Cardiometabolic conditions
  • COVID-19
  • Crohn's disease
  • Depression
  • Dermatology
  • Dyslipidemia
  • Endometriosis
  • Epilepsy
  • Hypertension
  • Insomnia
  • Irritable Bowel Syndrome
  • Migraine
  • PCOS
  • Psoriasis
  • Sleep Apnea
  • Type 2 Diabetes
  • Ulcerative Colitis
  • Uterine Fibroids

Who it serves

  • Academic Research
  • Consumer Health
  • Government
  • Life Sciences/Biopharma
  • Non-Profit

Deployment & integration

Cloud Saas deployment with recorded integration context.

Recorded integration context: 1upHealth, Apple Watch, Claims data, EHR systems, iPhone, Wearable devices.

Geographic context

MarketsMultiple geographies mentioned for platform licensing · United States (97% of ZIP codes)
Company sourceOfficial website

Company milestones

Platform expansion

Launched Interactive Dermatology Cohort (2024-2025), Launched Temporal Proteomics Platform for autoimmune research (2024-2025), Shared insights on real-world GLP-1 dosing behaviors from 60,000+ individuals (2024-2025), Appointed Dr. Ghazanfar Khan as Chief Medical Officer (2024-2025), Appointed Leslie Oley Wilberforce as CEO (2024-2025), Partnership with 1upHealth announced (2024-2025)

Partnerships

Recorded partners

  • 1upHealth
  • American College of Cardiology
  • Apple
  • BARDA
  • Johnson & Johnson
  • Myovant
  • Omada Health
  • RAND Corporation
  • Sanofi
  • USC

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Activation Platform

Drive awareness, engagement, and real-world action with patients

Platform · Cloud SaaSCompany source

Evidation App (Consumer)

Share health data with researchers, get insights, and earn rewards

Software · Cloud SaaSCompany source

Interactive Dermatology Cohort

Real-world insights on dermatology treatment journeys and outcomes

Service · Cloud SaaSCompany source

Patient Insights

Understand patient needs, preferences, and decision drivers

Service · Cloud SaaSCompany source

Prospective Studies

Sponsor-driven observational research with longitudinal data collection

Service · Cloud SaaSCompany source

Real-World Data Cohorts

Longitudinal, multimodal real-world data from direct patient connections

Platform · Cloud SaaSCompany source

Recruitment Services

Find and enroll the right trial participants from engaged community

Service · Cloud SaaSCompany source

Research & Engagement Platform (Licensed)

White-label platform for multi-year research programs with high engagement

Platform · Cloud SaaSCompany source

Temporal Proteomics Platform

AI-enabled platform for autoimmune biomarker discovery and modeling

Platform · Cloud SaaSCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

Research

Publications & preprints

Benefit of the N-of-1 Approach Versus Aggregate Analysis in Tracking Individual Trajectories During Pregnancy: Comparison of Longitudinal Wearable Observational Studies.

JMIR formative research · Apr 28, 2026

Model-Twin Randomization (MoTR) for Estimating the Recurring Individual Treatment Effect.

Statistics in medicine · Nov 1, 2025

American Life in Realtime: Benchmark, publicly available person-generated health data for equity in precision health.

PNAS nexus · Oct 1, 2025

Using Social Media to Engage and Enroll Underrepresented Populations: Longitudinal Digital Health Research.

JMIR formative research · Apr 15, 2025

Psychometric properties of the Federal Unit Scale for general psychopathology screening without iatrogenic effects.

Journal of psychiatric research · Apr 1, 2025

Identification of key factors related to digital health observational study adherence and retention by data-driven approaches: an exploratory secondary analysis of two prospective longitudinal studies.

The Lancet. Digital health · Jan 1, 2025

Clinical validation

Clinical-trial records

Healthy Living BEYOND Weight Study

NCT07075341 · Sponsor · RECRUITING

A Study to Investigate if Early Atrial Fibrillation (AF) Diagnosis Reduces Risk of Events Like Stroke in the Real-World

NCT04276441 · Mentioned · COMPLETED

Research and Engagement on Substance Use: Harnessing Awareness and Personalized Education (RESHAPE) to Improve Well-being and Self-efficacy

NCT06952491 · Sponsor · ENROLLING BY INVITATION

Predict + Protect Study: Exploring the Effectiveness of a Predictive Health Education Intervention on the Adoption of Protective Behaviors Related to ILI

NCT06229444 · Sponsor · COMPLETED

Wearable Assisted Viral Evidence (WAVE) Study A Decentralized, Prospective Study Exploring the Relationship Between Passively-collected Data From Wearable Activity Devices and Respiratory Viral Infections

NCT06207929 · Sponsor · COMPLETED

Evaluation of a Digital Diabetes Self-Management Education and Support Program

NCT05368454 · Sponsor · COMPLETED

Regulatory

Regulatory records

No linked records are currently available.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

90% average program engagement

Participant retention in research programs

89% average response rate

Content engagement in app

80%+ protocol compliance

Research study adherence

90%+ participant retention

Long-term study participation

Up to 2x increase in vaccination rates

Type 2 diabetes flu vaccine education program with Sanofi

American College of Cardiology (ACC)

Heart Health patient engagement program to allow cardiovascular patients to track everyday health and proactively manage care beyond traditional clinical settings

33,000 participants joined; 87% of individuals who shared personalized insights report with care team found it helpful or extremely helpful

BARDA (Biomedical Advanced Research and Development Authority)

FluSmart flu monitoring program to collect rich, longitudinal data and activate high-risk participants into research and care

200,000+ individuals participated with 90%+ engagement rate

Internal COVID-19 Research

Study to demonstrate that person-generated health data from smartphones and wearables can enable early warnings and population-level hotspot detection for COVID-19

800+ individuals recruited with >80% compliance with study activities

Johnson & Johnson

Multi-year observational study to assess whether the Heartline Study app on iPhone and Apple Watch can reduce stroke likelihood and improve health outcomes with earlier detection of atrial fibrillation

30,000+ participants aged 65+ enrolled

Myovant

4-month direct-to-patient study to uncover significant unmet needs among individuals with uterine fibroids

350 women with uterine fibroids enrolled; 92% weekly survey completion and 85% daily survey completion

Omada Health

Pilot study to demonstrate value of digital hypertension self-management program by quantifying impact on blood pressure control

151 individuals with hypertension recruited; published evidence that app improves blood pressure and medication adherence

Sanofi

Test and refine content and messaging for Type 2 diabetes flu vaccine education program to increase treatment rates

10,000 individuals recruited; up to 2x increase in vaccination rates for participants who engaged with customized diabetes campaign vs. generic messaging

USC and RAND Corporation

American Life in Real-time (ALiR) - first-of-its-kind, publicly available benchmark registry and research infrastructure for person-generated health data from smartphones and wearables

Digital engagement program launched to more than 1,000 participants

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Dr. Ghazanfar Khan

Chief Medical Officer

06 · Company updates

Updates from Evidation

Recent articles published on Evidation's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Population Health & Healthcare Analytics

Companies providing AI-powered analytics for population health management, healthcare data integration and analysis, risk stratification, care gap identification, or value-based care analytics. Focuses on analyzing data across patient populations to improve outcomes at scale and enable data-driven decision-making across health systems.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon